Targeting the SUMO E2 Conjugating Enzyme Ubc9 Interaction for Anti-Cancer Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|1|51-54

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.1, 2009-01, pp. : 51-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ubiquitin-conjugating enzyme E2-EPF is overexpressed in cervical cancer and associates with tumor growth

By              

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1519-1525

Spandidos Publications

Access to resources Recommend Favorite

Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation

By Bose Mayil Vahanan   Gopal Gopisetty   Selvaluxmy Ganesharaja   Rajkumar Thangarajan  

International Journal of Radiation Biology, Vol. 88, Iss. 9, 2012-09 ,pp. : 629-634

Informa Healthcare

Access to resources Recommend Favorite

X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Design of Novel Anti-Cancer Agents TargetingAurora Kinases

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 25-34

Bentham Science Publishers

Access to resources Recommend Favorite

The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 869-880

Bentham Science Publishers

Access to resources Recommend Favorite